Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Drug-eluting metallic stents in urology.

Kallidonis PS, Georgiopoulos IS, Kyriazis ID, Al-Aown AM, Liatsikos EN.

Indian J Urol. 2014 Jan;30(1):8-12. doi: 10.4103/0970-1591.124198. Review.

2.

Nanoparticle drug- and gene-eluting stents for the prevention and treatment of coronary restenosis.

Yin RX, Yang DZ, Wu JZ.

Theranostics. 2014 Jan 8;4(2):175-200. doi: 10.7150/thno.7210. eCollection 2014. Review.

3.

Nanotechnology in interventional cardiology.

Cyrus T, Wickline SA, Lanza GM.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2012 Jan-Feb;4(1):82-95. doi: 10.1002/wnan.154. Epub 2011 Jul 11. Review.

4.

Are "treatment" bare metal stents superior to "control" bare metal stents? A meta-analytic approach.

Kent DM, Trikalinos TA.

Am Heart J. 2008 Apr;155(4):624-9, 629.e1-2. doi: 10.1016/j.ahj.2007.11.005. Epub 2008 Jan 18.

5.

Delivery of large biopharmaceuticals from cardiovascular stents: a review.

Takahashi H, Letourneur D, Grainger DW.

Biomacromolecules. 2007 Nov;8(11):3281-93. Epub 2007 Oct 12. Review.

6.

A meta-analysis of trials comparing Cypher and Taxus stents in patients with obstructive coronary artery disease.

Sidhu S, Shafiq N, Malhotra S, Pandhi P, Grover A.

Br J Clin Pharmacol. 2006 Jun;61(6):720-6. Review.

7.

The cell cycle: a critical therapeutic target to prevent vascular proliferative disease.

Charron T, Nili N, Strauss BH.

Can J Cardiol. 2006 Feb;22 Suppl B:41B-55B. Review.

Supplemental Content

Support Center